Skip to main content

Advertisement

Log in

Antitumor and antimetastatic activities of human recombinant interferon alpha A/D

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Human recombinant interferon alpha A/D (αA/D) was examined for its antitumor activity in several mouse tumor models using metastatic tumors, such as B16 melanoma F1, BL6 and F10, UV2237m fibrosarcoma, and K1735m melanoma. Therapeutic treatment with αA/D reduced the incidence of pulmonary metastasis and inhibited the tumor growth resulting in an increase of the mean survival time. Since αA/D also showed a prophylactic activity against the metastasis, its antitumor activity was suggested to be due to augmentation of the host defense systems. This was confirmed by the fact that αA/D inhibited thein vivo growth and incidence of pulmonary metastasis of B16 F1 sublines regardless of their sensitivity to the direct antiproliferative activity of the IFNin vitro.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balkwill, F., Taylor-Papadimitriou, J., Fantes, K. H., andSebesteny, A., 1980, Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice.European Journal of Cancer,16, 569–573.

    Google Scholar 

  2. Barlozzari, T., Leonhardt, J., Wiltrout, R. H., Herberman, R. B., andReynolds, C. W., 1985, Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.Journal of Immunology,134, 2783–2789.

    Google Scholar 

  3. Belardelli, F., Gresser, I., Maury, C., andMaunoury, M. T., 1982, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I.International Journal of Cancer,30, 813–820.

    Google Scholar 

  4. Belardelli, F., Gresser, I., Maury, C., andMaunoury, M. T., 1982, Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanism.International Journal of Cancer,30, 821–825.

    Google Scholar 

  5. Brouty-Boye, D., 1980, Inhibitory effects of interferons on cell multiplication.Lymphokine Reports, Vol. 1, edited by E. Pick (New York: Academic Press), pp. 99–112.

    Google Scholar 

  6. Brunda, M. J., Rosenbaum, D., andStern, L., 1984, Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: Correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.International Journal of Cancer,34, 421–426.

    Google Scholar 

  7. Brunda, M. J., andRosenbaum, D., 1984, Modulation of murine natural killer cell activityin vitro andin vivo by recombinant human interferons.Cancer Research,44, 597–601.

    Google Scholar 

  8. Goeddel, D. V., Yelverton, E., Ullrich, A., Heyneker, H. L., Miozzari, G., Holmes, W., Seeburg, P. H., Dull, T., May, L., Stebbing, N., Crea, R., Maeda, S., McCandliss, R., Sloma, A., Tabor, J. M., Gross, M., Familletti, P. C., andPestka, S., 1980, Human leukocyte interferon produced byE. coli is biologically active.Nature,287, 411–416.

    Google Scholar 

  9. Gresser, I., Brouty-Boye, D., Thomas, M. T., andMacieira-Coelho, A., 1970, Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L1210 cellsin vitro by interferon preparations.Proceedings of the National Academy of Sciences, U.S.A.,66, 1052–1058.

    Google Scholar 

  10. Gresser, I., Maury, C., andBrouty-Boye, D., 1972, Mechanism of the antitumor effect of interferon in mice.Nature,239, 167–168.

    Google Scholar 

  11. Gresser, I., andTovey, M. G., 1978, Antitumor effects of interferon.Biochimica Biophysica Acta,516, 231–247.

    Google Scholar 

  12. Kataoka, T., Matsuura, N., Oh-hashi, F., andSuhara, Y., 1985, Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.Cancer Research,45, 3548–3553.

    Google Scholar 

  13. Kimura, K., 1983, Overview of phase II study of human lymphoblastoid interferon (HLBI) for solid tumor and blood cancer in Japan.Interferons: Proceedings of the International Symposium on Interferon, edited by T. Kishida (Ohsaka: Japan Convention Service), pp. 157–162.

    Google Scholar 

  14. Kramer, M. J., Dennin, R., Kramer, C., Jones, G., Connell, E., Rolon, N., Gruarin, A., Kale, R., andTrown, P. W., 1983, Cell and virus sensitivity studies with recombinant human alpha interferon.Journal of Interferon Research,3, 425–435.

    Google Scholar 

  15. Lee, S. H., Chiu, H., Rinderknecht, E., Sabo, W., andStebbing, N., 1983, Importance of treatment regimen of interferon as an antitumor agent.Cancer Research,43, 4172–4175.

    Google Scholar 

  16. Minato, N., Reid, L., Cantor, H., Lengyel, P., andBloom, B. R., 1980, Mode of regulation of natural killer cell activity by interferon.Journal of Experimental Medicine,152, 124–137.

    Google Scholar 

  17. Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Escödi, J., Boll, W., Canntell, K., andWeissman, C., 1980, Synthesis inE. coli of a polypeptide with human leukocyte interferon activity.Nature,284, 316–320.

    Google Scholar 

  18. Nishimura, J.,Mitsui, K., andIshitsuka, H., 1984, Antitumor activity of human recombinant IFN alpha A/D against B16 melanoma.Proceedings of the Japanese Cancer Association, The 43rd Annual Meeting, 1141.

  19. Rehberg, E., Kelder, B., Hoal, E. G., andPestka, S., 1982, Specific molecular activities of recombinant and hybrid leukocyte interferons.Journal of Biological Chemistry,257, 11497–11502.

    Google Scholar 

  20. Reid, L. M., Minato, N., Gresser, I., Holland, J., Kadish, A., andBloom, B. R., 1981, Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and human prostatic tumors in athymic nude mice.Proceedings of the National Academy of Sciences, U.S.A.,78, 1171–1175.

    Google Scholar 

  21. Rubinstein, S., Familletti, P. C., andPestka, S., 1981, Convenient assay for interferons.Journal of Virology,37, 755–758.

    Google Scholar 

  22. Sonnenfeld, G., 1980, Modulation of immunity by interferon.Lymphokine Reports, Vol. 1, edited by E. Pick (New York: Academic Press), pp. 113–131.

    Google Scholar 

  23. Staehelin, T., Hobbs, D. S., Kung, H.-F., Lai, C.-Y., andPestka, S., 1981, Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies.Journal of Biological Chemistry,256, 9750–9754.

    Google Scholar 

  24. Taguchi, T., Takakura, K., Kimura, K., Ohta, K., Izuo, M., Koyama, Y., Niijima, T., Ikeda, S., andAkahoshi, Y., 1983, Clinical studies of recombinant leukocyte A interferon (rIFN-alpha A).Interferons: Proceedings of International Symposium on Interferon, edited by T. Kishida (Ohsaka: Japan Convention Service), pp. 173–180.

    Google Scholar 

  25. Uno, K., Shimizu, S., Ido, M., Naito, K., Inaba, K., Oku, T., Kishida, T., andMuramatsu, S., 1985, Direct and indirect effects of interferon onin vivo murine tumor cell growth.Cancer Research,45, 1320–1327.

    Google Scholar 

  26. Weck, P. K., Rinderknecht, E., Estell, D. A., andStebbing, N., 1982, Antiviral activity of bacteria derived human alpha interferons against encephalomyocarditis virus infection of mice.Infection and Immunity,35, 660–665.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishimura, J., Mitsui, K., Ishikawa, T. et al. Antitumor and antimetastatic activities of human recombinant interferon alpha A/D. Clin Exp Metast 3, 295–304 (1985). https://doi.org/10.1007/BF01585083

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01585083

Keywords

Navigation